Atrial Arrhythmia Clinical Trial
Official title:
Multi-center, Randomized, Controlled Trial to Compare Feasibility, Safety and Efficacy of Zero-Fluoroscopic Navigation With Conventional Fluoroscopic Navigation for the Ablation of Right Atrial Arrhythmias
This study is intended to compare the feasibility, safety and efficacy of a zero-fluoroscopic approach with conventional fluoroscopic approach as performing catheter ablation of right atrial arrhythmias.
Catheter ablation is a well-established treatment to treat patients with a wide range of heart rhythm disturbances. Fluoroscopy is the imaging modality routinely used for cardiac device implantation and electrophysiological procedures. Due to the rising concern regarding the harmful effects of radiation exposure to both the patients and operation staffs, novel three-dimensional mapping systems such as Ensite NavX have been developed and implemented in electrophysiological procedure for the navigation of catheters inside the heart chambers. Ensite NavX is a promising system to guide catheters inside the cardiac chambers and vessels without the use of fluoroscopy. This study is intended to compare the feasibility, safety and efficacy of a zero-fluoroscopic approach with conventional fluoroscopic approach as performing catheter ablation of right atrial arrhythmias. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02245009 -
Safety of External Electrocardioversion in Device Patients
|
N/A | |
| Completed |
NCT02241382 -
Cologne Cardioversion Study
|
N/A | |
| Completed |
NCT01439386 -
Impact Of Different Ablation Approaches on Outcome In Coexistent Atrial Fibrillation and Flutter
|
Phase 3 | |
| Not yet recruiting |
NCT06293430 -
Registry on Luma Vision's VERAFEYE System (ENLIgHT)
|
||
| Recruiting |
NCT03209583 -
ATrial Tachycardia PAcing Therapy in Congenital Heart
|
||
| Recruiting |
NCT06083012 -
Clinical and Healthcare Economic OutcoMes From ReAl-worlD Use in Europe of an AI Software During AF Ablation
|
||
| Recruiting |
NCT05883631 -
RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.
|
N/A | |
| Recruiting |
NCT05434650 -
Abbott Atrial Fibrillation Post Approval Study
|
||
| Recruiting |
NCT05014802 -
Baseline Atrial Fibrosis Predicts Risk for Post-operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
|
||
| Completed |
NCT05113056 -
AcQForce Pulsed Field Ablation-CE
|
N/A | |
| Completed |
NCT05362656 -
AutoMatic disPERsion Tagging Function Preliminary Evaluation
|
N/A | |
| Recruiting |
NCT05411614 -
Hybrid AbLaTion of Atrial Fibrillation
|
N/A | |
| Active, not recruiting |
NCT05213104 -
Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Arrhythmia or Tachycardia
|
Phase 3 | |
| Active, not recruiting |
NCT03053843 -
Mediterranean Diet Plus Extravirgin Olive Oil in the Prevention of Recurrent Arrhythmias. The PREDIMAR (PREvención Con DIeta Mediterránea de Arritmias Recurrentes) Trial
|
N/A | |
| Completed |
NCT01188356 -
EMERALD - AssEssment of CoMorbidities & Atrial ArRhythmiA Burden in DuaL-Chamber PaceD Patients
|
||
| Recruiting |
NCT03458273 -
Real Zero Fluoroscopy Catheter Ablation.
|
||
| Completed |
NCT04394923 -
Relationship Between the Posterior Atrial Wall and the Esophagus: Esophageal Position and Temperature MEasurement During Atrial Fibrillation Ablation.
|
N/A | |
| Completed |
NCT02106663 -
Effectiveness Study of Circumferential vs. Segmental Ablation in Paroxysmal Atrial Fibrillation
|
N/A | |
| Completed |
NCT03854149 -
Apixaban in Adults With Congenital Heart Disease and Atrial Arrhythmias: the PROTECT-AR Study
|
||
| Recruiting |
NCT05488470 -
QT Changes as Detected From LINQ ECG During and After Antiarrhythmic Loading (LINQ QT)
|